Recent research:
The body of work aggregates pragmatic public health and biomedical inquiries spanning infectious disease surveillance, natural product pharmacology, and quality/standardization in healthcare technology. Across studies, the author investigates zoonotic and food-borne risk interfaces—such as seroprevalence of Influenza A and Toxoplasma gondii in guinea pigs raised as livestock in the Andean region—and assesses biosurveillance implications for panzootic outbreaks. Complementary lines examine plant-derived antimicrobials and their potential as natural preservatives or treatments, highlighting Curcuma longa, Taraxacum officinale, Melissa officinalis, Cymbopogon citratus, and Rosmarinus graveolens derivatives. Methodologies combine serology, microbiological assays (Kirby-Bauer, MIC), phytochemical screening, bioautography, and standard quality-control frameworks for medical equipment. The overarching impact emphasizes integrating veterinary/public health surveillance with ethnobotanical pharmacology to identify accessible, evidence-based strategies for infection control, acne management, cosmetic preservation, and laboratory efficiency. The research demonstrates potential translational benefits from traditional or botanical products while underscoring the need for standardized testing, concentration-dependent efficacy, and region-specific epidemiology to inform policy and practice.